December 11, 2009 (FinancialWire) — Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) a developer and producer of prescription drugs and licensed national seller of pharmaceutical products in the People’s Republic of China, said that Liang Fang, a controlled operating entity of Lotus, has appointed Jinzhong Han to be general manager of the company’s Over-the-Counter Drug division.

Han was general manager of the OTC Division of Tianjin Taiping Pharmaceutical for two years. Prior to that, he served approximately seven years as vice general manager and Chief of Marketing officer of Beijing Yongkang Pharmaceutical company.

China-based Lotus Pharmaceuticals operates Liang Fang Pharmaceutical and En Ze Jia Shi Pharmaceutical. Lotus’ current drug development pipeline is focused on the treatment of cerebro-cardiovascular disease, asthma, and diabetes.

FinancialWire(tm) is a fully independent, proprietary news wire service. FinancialWire(tm) is not a press release service, and receives no compensation for its news, opinions or distributions. Further disclosure is at the FinancialWire(tm) web site (http://www.financialwire.net/disclosures.php). Contact FinancialWire(tm) directly via inquiries@financialwire.net.

Free annual reports for companies mentioned in the news are available through the Free Annual Reports Service (http://investrend.ar.wilink.com/?level=279).

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.